Patents by Inventor Gary D. Niehaus

Gary D. Niehaus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7947492
    Abstract: A device and method is disclosed for improving the detection of a ligand by a receptor by concentrating microbes by removing particulates from fluid-borne samples and/or causing selective aggregation of concentrated microbes. The device may be configured as a multipath valve capable purifying/concentrating a sample in one orientation and delivering the concentrated sample in another orientation. In one embodiment, the device includes a body that defines a plurality of chambers and pathways and supports a pathogen capture unit that houses a receptor that exhibits specificity for a ligand. In another embodiment, the capture unit houses a plurality of antibody coated generally spherical particles capable of binding to a ligand.
    Type: Grant
    Filed: August 20, 2008
    Date of Patent: May 24, 2011
    Assignee: Northeastern Ohio Universities College of Medicine
    Inventor: Gary D. Niehaus
  • Patent number: 7927827
    Abstract: A system for the detection of ligands comprising at least one receptor and an amplification mechanism coupled to the receptor wherein an amplified signal is produced as a result of receptor binding a ligand. Examples of suitable amplification mechanisms include antibody-embedded liquid crystalline materials; use of alpha-2-macroglobulin to encage an enzyme, whereby the enzyme is separated from its substrate by an receptor; and a receptor engineered to inhibit the active of site of an enzyme only in the absence of a ligand. Also provided are methods for the automatic detection of ligands.
    Type: Grant
    Filed: May 21, 2007
    Date of Patent: April 19, 2011
    Assignee: Kent State University
    Inventors: Gary D. Niehaus, Christopher J. Woolverton, Kathleen J. Doane, Steven P. Schmidt, Steven A. Signs
  • Patent number: 7811811
    Abstract: The invention relates to self-contained assay cassette for detecting a ligand in a sample. The assay cassette provides for turbulent flow and mixing of the sample with assay components, including receptors that bind to a ligand, optional microspheres capable of binding the receptors or to which other secondary receptors are attached, and liquid crystalline materials. The assay cassette also provides for laminar flow of the mixed sample into a detection chamber where complexes between a receptor, ligand, and optional microspheres, is detected as transmission of polarized light through the detection chambers. The invention also relates to methods for detecting a ligand in a sample using turbulent flow to mix the sample with assay components, including liquid crystalline materials, and laminar flow of the mixed sample such that the liquid crystalline material assumes an ordered conformation in absence of a ligand.
    Type: Grant
    Filed: June 7, 2006
    Date of Patent: October 12, 2010
    Assignee: Northeastern Ohio Universities College of Medicine
    Inventor: Gary D. Niehaus
  • Patent number: 7732219
    Abstract: A system for the detection of ligands comprising at least one receptor and an amplification mechanism coupled to the receptor wherein an amplified signal is produced as a result of receptor binding a ligand. Examples of suitable amplification mechanisms include antibody-embedded liquid crystalline materials; use of alpha-2-macroglobulin to encage an enzyme, whereby the enzyme is separated from its substrate by an receptor; and a receptor engineered to inhibit the active of site of an enzyme only in the absence of a ligand. Also provided are methods for the automatic detection of ligands.
    Type: Grant
    Filed: September 10, 2007
    Date of Patent: June 8, 2010
    Assignee: Kent State University
    Inventors: Christopher J. Woolverton, Gary D. Niehaus, Kathleen J. Doane, Oleg D. Lavrentovich, Steven P. Schmidt, Steven A. Signs
  • Publication number: 20100047920
    Abstract: A device and method is disclosed for improving the detection of a ligand by a receptor by concentrating microbes by removing particulates from fluid-borne samples and/or causing selective aggregation of concentrated microbes. The device may be configured as a multipath valve capable purifying/concentrating a sample in one orientation and delivering the concentrated sample in another orientation. In one embodiment, the device includes a body that defines a plurality of chambers and pathways and supports a pathogen capture unit that houses a receptor that exhibits specificity for a ligand. In another embodiment, the capture unit houses a plurality of antibody coated generally spherical particles capable of binding to a ligand.
    Type: Application
    Filed: August 20, 2008
    Publication date: February 25, 2010
    Applicant: NORTHEASTERN OHIO UNIVERSITIES COLLEGE OF MEDICINE
    Inventor: Gary D. Niehaus
  • Patent number: 7407815
    Abstract: A functional cassette for the detection of ligands comprises a first inner housing, a second middle housing and a third outer housing and each housing is at least partially rotatable relative to an adjoining housing. The first inner housing contains a central well adapted for receiving a sample, and the central well is in selectable fluid communication with at least one mixing chambers. The mixing chambers contain a reagent for forming a complex with a ligand. The first inner housing additionally comprises at least one compartments for the storage of a liquid crystalline material, and the compartments are in selectable fluid communication with at least one mixing chambers. The third outer housing comprises at least one detection chambers for observing the light transmission properties of a liquid crystal material and the detection chambers are in selectable fluid communication with the mixing.
    Type: Grant
    Filed: September 27, 2006
    Date of Patent: August 5, 2008
    Assignees: Kent State University, Northeastern Ohio Universities College of Medicine
    Inventors: Christopher J. Woolverton, Gary D. Niehaus
  • Publication number: 20080138244
    Abstract: A system for the detection of ligands comprising at least one receptor and an amplification mechanism coupled to the receptor wherein an amplified signal is produced as a result of receptor binding a ligand. Examples of suitable amplification mechanisms include antibody-embedded liquid crystalline materials; use of alpha-2-macroglobulin to encage an enzyme, whereby the enzyme is separated from its substrate by an receptor; and a receptor engineered to inhibit the active of site of an enzyme only in the absence of a ligand. Also provided are methods for the automatic detection of ligands.
    Type: Application
    Filed: September 10, 2007
    Publication date: June 12, 2008
    Applicant: KENT STATE UNIVERSITY
    Inventors: Christopher J. Woolverton, Gary D. Niehaus, Kathleen J. Doane, Oleg D. Lavrentovich, Steven P. Schmidt, Steven A. Signs
  • Patent number: 7267957
    Abstract: A system for the detection of ligands comprising at least one receptor and an amplification mechanism coupled to the receptor wherein an amplified signal is produced as a result of receptor binding a ligand. Examples of suitable amplification mechanisms include antibody-embedded liquid crystalline materials; use of alpha-2-macroglobulin to encage an enzyme, whereby the enzyme is separated from its substrate by an receptor; and a receptor engineered to inhibit the active of site of an enzyme only in the absence of a ligand. Also provided are methods for the automatic detection of ligands.
    Type: Grant
    Filed: April 26, 2002
    Date of Patent: September 11, 2007
    Assignee: Kent State University
    Inventors: Christopher J Woolverton, Gary D Niehaus, Kathleen J Doane, Oleg D Lavrentovich, Steven P Schmidt, Steven A Signs
  • Patent number: 7160736
    Abstract: Devices and systems for the detection of ligands comprising at least one receptor and an amplification mechanism comprising a liquid crystalline, where an amplified signal is produced as a result of receptor binding to a ligand are provided. Also provided are methods for the automatic detection of ligands.
    Type: Grant
    Filed: December 1, 2003
    Date of Patent: January 9, 2007
    Assignee: Kent State University
    Inventors: Gary D. Niehaus, Christopher J. Woolverton, Oleg D. Lavrentovich
  • Patent number: 7060225
    Abstract: The invention relates to self-contained assay cassette for detecting a ligand in a sample. The assay cassette provides for turbulent flow and mixing of the sample with assay components, including receptors that bind to a ligand, optional microspheres capable of binding the receptors or to which other secondary receptors are attached, and liquid crystalline materials. The assay cassette also provides for laminar flow of the mixed sample into a detection chamber where complexes between a receptor, ligand, and optional microspheres, is detected as transmission of polarized light through the detection chambers. The invention also relates to methods for detecting a ligand in a sample using turbulent flow to mix the sample with assay components, including liquid crystalline materials, and laminar flow of the mixed sample such that the liquid crystalline material assumes an ordered conformation in absence of a ligand.
    Type: Grant
    Filed: March 22, 2004
    Date of Patent: June 13, 2006
    Assignee: Northeastern Ohio Universities College of Medicine
    Inventor: Gary D. Niehaus
  • Publication number: 20040185551
    Abstract: The invention relates to self-contained assay cassette for detecting a ligand in a sample. The assay cassette provides for turbulent flow and mixing of the sample with assay components, including receptors that bind to a ligand, optional microspheres capable of binding the receptors or to which other secondary receptors are attached, and liquid crystalline materials. The assay cassette also provides for laminar flow of the mixed sample into a detection chamber where complexes between a receptor, ligand, and optional microspheres, is detected as transmission of polarized light through the detection chambers. The invention also relates to methods for detecting a ligand in a sample using turbulent flow to mix the sample with assay components, including liquid crystalline materials, and laminar flow of the mixed sample such that the liquid crystalline material assumes an ordered conformation in absence of a ligand.
    Type: Application
    Filed: March 22, 2004
    Publication date: September 23, 2004
    Applicant: Northeastern Ohio Universities College of Medicine
    Inventor: Gary D. Niehaus
  • Publication number: 20040175841
    Abstract: Devices and systems for the detection of ligands comprising at least one receptor and an amplification mechanism comprising a liquid crystalline, where an amplified signal is produced as a result of receptor binding to a ligand are provided. Also provided are methods for the automatic detection of ligands.
    Type: Application
    Filed: December 1, 2003
    Publication date: September 9, 2004
    Applicant: Kent State University
    Inventors: Gary D. Niehaus, Christopher J. Woolverton, Oleg D. Lavrentovich
  • Publication number: 20020052002
    Abstract: Devices and systems for the detection of ligands comprising at least one receptor and an amplification mechanism comprising a liquid crystalline, where an amplified signal is produced as a result of receptor binding to a ligand are provided. Also provided are methods for the automatic detection of ligands.
    Type: Application
    Filed: March 29, 2001
    Publication date: May 2, 2002
    Inventors: Gary D. Niehaus, Christopher J. Woolverton, Oleg D. Lavrentovich, Tomohiro Ishikawa, Kathleen J. Doane
  • Patent number: 6171802
    Abstract: A system for the detection of ligands comprising at least one receptor and an amplification mechanism coupled to the receptor wherein an amplified signal is produced as a result of receptor binding a ligand. Examples of suitable amplification mechanisms include antibody-embedded liquid crystalline materials; use of alpha-2-macroglobulin to encage an enzyme, whereby the enzyme is separated from its substrate by an receptor; and a receptor engineered to inhibit the active of site of an enzyme only in the absence of a ligand. Also provided are methods for the automatic detection of ligands.
    Type: Grant
    Filed: June 10, 1998
    Date of Patent: January 9, 2001
    Assignee: Kent State University
    Inventors: Christopher J. Woolverton, Gary D. Niehaus, Kathleen J. Doane, Oleg Lavrentovich, Steven P. Schmidt, Steven A. Signs